A federal appeals court yesterday handed a win to Medtronic (NYSE:MDT) that could wind up helping Twin Cities rival St. Jude Medical (NYSE:STJ), in a pair of decisions concerning patents covering remote patient monitoring technology.
In the Medtronic case, the U.S. Court of Appeals for the Federal Circuit ruled that a lower court judge wrongly interpreted the patent, overturning validity decision in favor of Atlas IP and remanding the case back to the U.S. District Court for Southern Florida. The Federal Circuit also upheld Judge Cecilia Altonaga’s judgment of non-infringement in favor of Medtronic.
That could help St. Jude in its fight with Atlas. The appeals court yesterday also vacated Altonaga’s non-infringement judgment against Atlas, likewise sending that case back to the Southern Florida court.